Atlas Trials

Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy

Clinical trial NCT01677377 · COMPLETED

Trial details

NCT number
NCT01677377
Sponsor
Indivior Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2012-08-01
Primary completion
2013-04-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.